These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 7677445)

  • 21. Time lag between active joint inflammation and radiological progression in patients with early rheumatoid arthritis.
    Matsuda Y; Yamanaka H; Higami K; Kashiwazaki S
    J Rheumatol; 1998 Mar; 25(3):427-32. PubMed ID: 9517758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin 10 (IL-10), not IL-4 or interferon-gamma production, correlates with progression of joint destruction in rheumatoid arthritis.
    Verhoef CM; van Roon JA; Vianen ME; Bijlsma JW; Lafeber FP
    J Rheumatol; 2001 Sep; 28(9):1960-6. PubMed ID: 11550960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Very recent onset arthritis--clinical, laboratory, and radiological findings during the first year of disease.
    Machold KP; Stamm TA; Eberl GJ; Nell VK; Dunky A; Uffmann M; Smolen JS
    J Rheumatol; 2002 Nov; 29(11):2278-87. PubMed ID: 12415582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiographic outcome of recent-onset rheumatoid arthritis: a 19-year study of radiographic progression.
    Wolfe F; Sharp JT
    Arthritis Rheum; 1998 Sep; 41(9):1571-82. PubMed ID: 9751089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of serum interleukin-6 level as a surrogate marker of synovial inflammation and as a factor of structural progression in early rheumatoid arthritis: results from a French national multicenter cohort.
    Baillet A; Gossec L; Paternotte S; Etcheto A; Combe B; Meyer O; Mariette X; Gottenberg JE; Dougados M
    Arthritis Care Res (Hoboken); 2015 Jul; 67(7):905-12. PubMed ID: 25384758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammatory patterns in rheumatoid arthritis estimated by the number of swollen and tender joints, the erythrocyte sedimentation rate, and hemoglobin: longterm course and association to radiographic progression.
    Graudal N; Tarp U; Jurik AG; Galløe AM; Garred P; Milman N; Graudal HK
    J Rheumatol; 2000 Jan; 27(1):47-57. PubMed ID: 10648017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between time-integrated C-reactive protein levels and radiologic progression in patients with rheumatoid arthritis.
    Plant MJ; Williams AL; O'Sullivan MM; Lewis PA; Coles EC; Jessop JD
    Arthritis Rheum; 2000 Jul; 43(7):1473-7. PubMed ID: 10902748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Significance of v-raf murine sarcoma viral oncogene homologue B1 in rheumatoid arthritis].
    Jin YJ; Sun L; Yang L; Xing R; Liu XY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):947-950. PubMed ID: 27987495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-6, soluble interleukin-2 receptor and soluble interleukin-6 receptor in the sera of patients with different histological patterns of rheumatoid synovitis.
    Klimiuk PA; Sierakowski S; Latosiewicz R; Cylwik JP; Cylwik B; Skowronski J; Chwiecko J
    Clin Exp Rheumatol; 2003; 21(1):63-9. PubMed ID: 12673891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thresholds for the 28-joint disease activity score (DAS28) using C-reactive protein are lower compared to DAS28 using erythrocyte sedimentation rate in early rheumatoid arthritis.
    Kuriya B; Schieir O; Lin D; Xiong J; Pope J; Boire G; Haraoui B; Thorne JC; Tin D; Hitchon C; Jamal S; Keystone E; Bykerk VP;
    Clin Exp Rheumatol; 2017; 35(5):799-803. PubMed ID: 28339365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of elevated serum interleukin-6 levels in rheumatoid arthritis: correlation with erythrocyte sedimentation rate or C-reactive protein.
    Cohick CB; Furst DE; Quagliata S; Corcoran KA; Steere KJ; Yager JG; Lindsley HB
    J Lab Clin Med; 1994 May; 123(5):721-7. PubMed ID: 8195678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythrocyte sedimentation rate and C-reactive protein levels are poorly correlated with clinical measures of disease activity in rheumatoid arthritis, systemic lupus erythematosus and osteoarthritis patients.
    Keenan RT; Swearingen CJ; Yazici Y
    Clin Exp Rheumatol; 2008; 26(5):814-9. PubMed ID: 19032813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rheumatoid factor measured by fluoroimmunoassay: a responsive measure of rheumatoid arthritis disease activity that is associated with joint damage.
    Knijff-Dutmer E; Drossaers-Bakker W; Verhoeven A; van der Sluijs Veer G; Boers M; van der Linden S; van de Laar M
    Ann Rheum Dis; 2002 Jul; 61(7):603-7. PubMed ID: 12079900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Which measure of inflammation to use? A comparison of erythrocyte sedimentation rate and C-reactive protein measurements from randomized clinical trials of golimumab in rheumatoid arthritis.
    Crowson CS; Rahman MU; Matteson EL
    J Rheumatol; 2009 Aug; 36(8):1606-10. PubMed ID: 19531760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased serum amyloid A and its association with autoantibodies, acute phase reactants and disease activity in patients with rheumatoid arthritis.
    Shen C; Sun XG; Liu N; Mu Y; Hong CC; Wei W; Zheng F
    Mol Med Rep; 2015 Feb; 11(2):1528-34. PubMed ID: 25352049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of age on 3 year outcome in early rheumatoid arthritis.
    Peltomaa R; Leirisalo-Repo M; Helve T; Paimela L
    J Rheumatol; 2000 Mar; 27(3):638-43. PubMed ID: 10743801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential response of serum amyloid A to different therapies in early rheumatoid arthritis and its potential value as a disease activity biomarker.
    Hwang YG; Balasubramani GK; Metes ID; Levesque MC; Bridges SL; Moreland LW
    Arthritis Res Ther; 2016 May; 18(1):108. PubMed ID: 27188329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Red blood cell distribution width: a potential laboratory parameter for monitoring inflammation in rheumatoid arthritis.
    He Y; Liu C; Zeng Z; Ye W; Lin J; Ou Q
    Clin Rheumatol; 2018 Jan; 37(1):161-167. PubMed ID: 29101675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset.
    Berglin E; Johansson T; Sundin U; Jidell E; Wadell G; Hallmans G; Rantapää-Dahlqvist S
    Ann Rheum Dis; 2006 Apr; 65(4):453-8. PubMed ID: 16176994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Baseline serum level of matrix metalloproteinase-3 as a biomarker of progressive joint damage in rheumatoid arthritis patients.
    Galil SM; El-Shafey AM; Hagrass HA; Fawzy F; Sammak AE
    Int J Rheum Dis; 2016 Apr; 19(4):377-84. PubMed ID: 25292349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.